Author | Edward Bradley, MD | OncLive

Author | Edward Bradley, MD

Articles

Dr. Bradley on OX40 for the Treatment of Cancer

August 28, 2013

Video

Edward Bradley, MD, from MedImmune (the global biologics research and development arm of AstraZeneca), describes the development of an agonist for the treatment of cancer.

Dr. Bradley Discusses Moxetumomab Pasudotox

July 30, 2013

Video

Edward Bradley, MD, Senior Vice President, Head, Innovative Medicines unit (iMED), MedImmune (the global biologics research and development arm of AstraZeneca), discusses the development of moxetumomab pasudotox.

x